As concern over the deadly coronavirus grows, fake news and scams capitalising on people’s fears are also spreading. On February the 8th confirmed data on Coronavirus 2019-nCoV Global Cases by Johns Hopkins CSSE dashboard early 34,600 people have been infected and more than 700 have died in China, with the majority of the cases in Hubei province. Outside
An in-depth annotation of the newly discovered coronavirus (2019-nCoV) genome has revealed differences between 2019-nCoV and severe acute respiratory syndrome (SARS) or SARS-like coronaviruses. A systematic comparison identified 380 amino acid substitutions between these coronaviruses, which may have caused functional and pathogenic divergence of 2019-nCoV. In a paper just published on Cell Host & Microbe
In the first clinical study of its kind in the US, researchers used CRISPR to modify CAR T cells to make them more potent against cancer, but the clinical benefits are unknown. mmune cells altered by CRISPR are safe to use in cancer patients, according to results of a clinical trial reported February 6 in Science.
Workshops took place across the country to focus on the pivotal role of advanced therapies apprenticeships in addressing the skills demand in the industry. Apprentices, employers, schools and careers professionals were in attendance to consider the impact of the ATAC initiative so far and how to enhance its reach moving forward. During national apprenticeship week, the
The way research in bioprinting will be taken forward has been laid out in a roadmap for the field. Published today in IOP Publishing’s Biofabrication, leading researchers define the status, challenges and opportunities in the field, and forecast the required advances in science & technology to overcome the challenges to a range of bioprinting techniques and applications.
As the relentless spread of the coronavirus continued, scientists around the world are working round the clock to find the right cure. Till now, there is no approved treatment for the infection, and only symptoms are being treated across the globe. Till now, confirmed cases of the outbreak has been reported from 24 countries, including
Cell therapies hold significant promise for the treatment of injured or diseased musculoskeletal tissues. However, despite advances in research, there is growing concern about the increasing number of clinical centres around the world that are making unwarranted claims or are performing risky biological procedures. On The Bone and Joint Journal has just been published a
Epidemiologist Sergios-Orestis Kolokotronis, PhD, and scientists from Taiwan, Munich, Berkeley and Madison are examining genome data from every confirmed case of 2019-nCoV to unearth insights into viral emergence Twice each day, SUNY Downstate School of Public Health evolutionary epidemiologist Sergios-Orestis Kolokotronis, PhD, joins a global group of scientists in reviewing a worldwide database of the
Urgent support needed to protect vulnerable countries from outbreak To fight further spread of the new coronavirus (2019-nCoV) outbreak in China and globally, and protect states with weaker health systems, the international community has launched a US$675 million preparedness and response plan covering the months of February through to April 2020. “My biggest worry is
Researchers at Albany Medical College in New York have discovered that a specific type of immune cell accumulates in older brains, and that activating these cells improves the memory of aged mice. The study, which has been published February 5 in the Journal of Experimental Medicine (JEM), suggests that targeting these cells might reduce age-related cognitive decline
